![]() Curetis Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases. | Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. | ![]() Novoprotein Novoprotein (also known as 诺唯赞) is a biotechnology company that develops and supplies recombinant proteins, reagents, and contract research and manufacturing services for biopharmaceutical and research purposes. | |
Founding Date | Founding Date 2007 | Founding Date 2008 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Holzgerlingen, DE HQ | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US | |
Employees | Employees 57 | Employees 8154% increase | Employees 566 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.6 b | Valuation ($) 340 m |
Financial | |||
Revenue (est.) | Revenue (est.) €1.4m (FY, 2018) | Revenue (est.) $517.1m (FY, 2025) | Revenue (est.) ¥144.6m (FY, 2025) |
Cost of goods | Cost of goods €2m (FY, 2018) | Cost of goods N/A | Cost of goods ¥48.1m (FY, 2025) |
Gross profit | Gross profit €138k (FY, 2018) | Gross profit $362.5m (FY, 2025) | Gross profit ¥96.8m (FY, 2025) |
Net income | Net income (€23.7m) (FY, 2018) | Net income $66.4m (FY, 2025) | Net income (¥77.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 67.8m | Total funding raised $ 116.3m | Total funding raised N/A |
Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View company
Novoprotein (also known as 诺唯赞) is a biotechnology company that develops and supplies recombinant proteins, reagents, and contract research and manufacturing services for biopharmaceutical and research purposes.
View company